Acute Lymphoblastic Leukemia Registry at Asan Medical Center

Asan Medical Center

Status: Terminated

Conditions: Leukemia, Biphenotypic, Acute; Leukemia, Acute Lymphoblastic; Precursor B-Cell Lymphoblastic Leukemia; Lymphoblastic Lymphoma; Leukemia, Lymphoblastic, Acute, Philadelphia-Positive

Treatments: Other: Diagnosed as ALL

Study type: Observational

Funder types: Other

Identifiers

NCT01761682

AMC-HEMREG-ALL

Details and patient eligibility

About

The investigators would like to propose a prospective longitudinal observational cohort study for patients who will be diagnosed and/or treated for acute lymphoblastic leukemia at Asan Medical Center, Seoul, Korea, to use the acquired data for fundamentals of other retrospective analysis.

Full description

1. Acquisition of informed concent form

2. Data acquisition from medical record including

   • demographic / disease-associated factors
   • details of treatment, and its results
   • complications during treatment
   • genetic data
   • survival outcome (upto 10 years)

3. Accumulation of data for 30 years

4. Use of data for other retrospective analysis (including Asan Medical center Cell Banking basic data)

Enrollment: 200 patients

Sex: All

Ages: 15+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• All patients who are diagnosed and/or treated as acute lymphoblastic leukemia at Asan Medical Center (including biphenotypic acute leukemia with Philadelphila-positive, Burkitt leukemia/lymphoma)
• 15 years of age and over
• All patients who give written consent according to guidelines at Asan Medical Center committee on human research

Exclusion criteria

• Patients who refuse to give consent to registering

Trial design

200 participants in 3 patient groups

Ph-ALL

Description:

Diagnosed as ALL with Philadelphia-negative

Treatment:

Other: Diagnosed as ALL

Ph+ALL

Description:

Diagnosed as ALL with Philadelphia-positive (including biphenotypic acute leukemia with Philadelphia-positive)

Treatment:

Other: Diagnosed as ALL

Other ALL

Description:

Diagnosed as ALL of other type, including Burkitt leukemia

Treatment:

Other: Diagnosed as ALL